Sex-specific risk of cardiovascular disease and cognitive decline: Pregnancy and menopause

Biology of Sex Differences

Volumn 4, Issue 1, 2013, Pages

  Miller, Virginia M ^a   Garovic, Vesna D ^b   Kantarci, Kejal ^c   Barnes, Jill N ^c   Jayachandran, Muthuvel ^a   Mielke, Michelle M ^c   Joyner, Michael J ^c   Shuster, Lynne T ^d   Rocca, Walter A ^e  

^a MAYO GRADUATE SCHOOL   (United States)

^b Division of Nephrology and Hypertension   (United States)

^c Department of Radiology ^*  (United States)

^d Office of Women's Health   (United States)

^e Information Technology   (United States)

Author keywords

Brain imaging; Cerebral blood flow; Cognition; Estrogen; Hormone; Hypertension; Microvesicles; Preeclampsia; White matter hyperintensities

Indexed keywords

EID: 84892943167     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-4-6     Document Type: Review

References (251)

1. Sex CoUtBo, Differences G, Policy BoHS: Exploring the Biological Contributions to Human Health: Does Sex Matter?. Washington, DC: The National Academies Press; 2001.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al: Heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation 2012, 125(1):e2-e220.
3. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pina IL, Roger VL, Shaw LJ, et al: Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American heart association. Circulation 2011, 123(11):1243-1262.
4. Reckelhoff JF, Fortepiani LA: Novel mechanisms responsible for postmenopausal hypertension. Hypertension 2004, 43(5):918-923. (Pubitemid 38579888)
5. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK: Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005, 45(4):522-525. (Pubitemid 40411253)
6. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ: Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 2009, 53:571-576.
7. Hart EC, Charkoudian N, Miller VM: Sex, hormones and neuroeffector mechanisms. Acta Physiologica 2010, 203:155-165.
8. Regitz-Zagrosek V, Lehmkuhl E: Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen. Herz 2005, 30(5):356-367. (Pubitemid 41238953)
9. Arain FA, Kuniyoshi FH, Abdalrhim AD, Miller VM: Sex/gender medicine: the biological basis for personalized care in cardiovascular medicine. Circ J 2009, 73(10):1774-1782.
10. Zakeri R, Vallejo-Giraldo C, Taylor KE, Miller VM, Schaible NS: Using heart failure with preserved ejection fraction to understand an 'omics approach to evaluating vascular dysfunction and cardiovascular disease. J Neurol Neurophysiol 2011:S1-006.
11. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA: Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009, 40(4):1032-1037.
12. Gargano JW, Reeves MJ: Sex differences in stroke recovery and strokespecific quality of life: results from a statewide stroke registry. Stroke 2007, 38(9):2541-2548. (Pubitemid 47329635)
13. Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, Srikanth V, Thrift AG: Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010, 74(12):975-981.
14. Alzheimer's Association: 2012 Alzheimer's disease facts and figures. Alzheimers Dement 2012, 8:131-168.
15. Herbert LE, Weuve J, Scherr PA, Evans DA: Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013. doi:10.1212/WNL.0b013e31828726f5.
16. Sudhir K, Esler MD, Jennings GL, Komesaroff PA: Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997, 30:1538-1543. (Pubitemid 27528101)
17. Herbison AE, Simonian SX, Thanky NR, Bicknell RJ: Oestrogen modulation of noradrenaline neurotransmission. Novartis Found Symp 2000, 230:74-85. discussion 85-93.
18. Anglin JC, Brooks VL: Tyrosine hydroxylase and norepinephrine transporter in sympathetic ganglia of female rats vary with reproductive state. Auton Neurosci 2003, 105:8-15. (Pubitemid 36547898)
19. Moldovanova I, Shroeder C, Jacob G, Hiemke C, Diedrich A, Luft J J FC: Hormonal influences on cardiovascular norepinephrine transporter responses in healthy women. Hypertension 2008, 51(4):1203-1209. (Pubitemid 351398983)
20. Paden CM, McEwen BS, Fishman J, Snyder L, DeGroff V: Competition by estrogens for catecholamine receptor binding in vitro. J Neurochem 1982, 39(2):512-520. (Pubitemid 12013631)
21. Lloyd T, Weisz J: Direct inhibition of tyrosine hydroxylase activity by catechol estrogens. J Biol Chem 1978, 253:4841-4843. (Pubitemid 8382146)
22. Ball P, Knuppen R, Haupt M, Breuer H: Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the ctechol-O-methyltransferases of human liver. J Clin Endocrinol Metab 1972, 34(4):736-746.
23. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA: Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002, 87:1062-1067. (Pubitemid 36121066)
24. Bupha-Intr T, Wattanapermpool J: Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 2006, 291(3):H1101-1108. (Pubitemid 44343653)
25. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, et al: Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003, 290(13):1729-1738. (Pubitemid 37430623)
26. Liu PY, Christian RC, Ruan M, Miller VM, Fitzpatrick LA: Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab 2005, 90(2):1041-1046. (Pubitemid 40279231)
27. Vattikuti R, Towler DA: Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004, 286(5):E686-E696. (Pubitemid 38506938)
28. Prakash YS, Togaibayeva AA, Kannan MS, Miller VM, Fitzpatrick LA, Sieck GC: Estrogen increases [Ca2+] efflux from female porcine coronary arterial smooth muscle. Am J Physiol Heart Circ Physiol 1999, 45:H926-H934. (Pubitemid 29157465)
29. White RE, Darkow DJ, Falvo Lang JL: Estrogen relaxes coronary arteries by opening BKCachannels through a cGMP-dependent mechanism. Circ Res 1995, 77:936-942.
30. Deenadayalu VP, White RE, Stallone JN, Gao X, Garcia AJ: Testosterone relaxes coronary arteries by opening the large-conductance, calciumactivated potassium channel. Am J Physiol Heart Circ Physiol 2001, 281: H1720-H1727.
31. Miller VM, Duckles SP: Vascular actions of estrogens: functional implications. Pharmacol Rev 2008, 60(2):210-241. (Pubitemid 351962010)
32. Duckles SP, Miller VM: Hormonal modulation of endothelial NO production. Pflugers Arch Eur J Physiol 2010, 459:841-851.
33. Charkoudian N, Joyner MJ, Barnes SA, Johnson CP, Eisenach JH, Dietz NM, Wallin BG: Relationship between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans. Am J Physiol Heart Circ Physiol 2006, 291(3):H1378-1383. (Pubitemid 44343684)
34. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB, Wallin BG: Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 2006, 572(Pt 3):821-827.
35. Hart EC, Joyner MJ, Wallin BG, Johnson CP, Curry TB, Eisenach JH, Charkoudian N: Age-related differences in the sympathetic-hemodynamic balance in men. Hypertension 2009, 54(1):127-133.
36. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach J, Joyner MJ: Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J Physiol 2011, 589(Pt 21):5285-5297.
37. Charkoudian N, Joyner MJ, Johnson CP, Eisenach JH, Dietz NM, Wallin BG: Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 2005, 568:315-321. (Pubitemid 41448640)
38. Krause DN, Duckles SP, Pelligrino DA: Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006, 101(4):1252-1261. (Pubitemid 44497571)
39. Li W, Zheng T, Altura BM, Altura BT: Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascular smooth muscle cells: possible relationships to migraine frequency in premenstrual syndromes and stroke incidence. Brain Res Bull 2001, 54(1):83-89. (Pubitemid 32156919)
40. Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB: Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 1998, 34(2):171-182. (Pubitemid 28541758)
41. Mahmoodzadeh S, Dworatzek E, Fritschka S, Pham TH, Regitz-Zagrosek V: 17Beta-estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts. Cardiovasc Res 2010, 85(4):719-728.
42. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, et al: Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 2010, 298(6):R1597-1606.
43. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW: Estrogenreceptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor. Circulation 1997, 95(6):1505-1514. (Pubitemid 27142809)
44. Yuan M, Siegel C, Zeng Z, Li J, Liu F, McCullough LD: Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol 2009, 217(1):210-218.
45. Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD: Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci 2006, 7:74.
46. Wise PM, Dubal DB, Wilson ME, Rau SW, Liu Y: Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001, 22(1):33-66. (Pubitemid 32099717)
47. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183(1):S1-S22.
48. ACGO Committee on Obstetric Practice: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 77(1):67-75.
49. Saftlas AF, Olson DR, Franks AL, Atrash HK, Pokras R: Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990, 163(2):460-465. (Pubitemid 20287609)
50. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, DerSimonian R, Esterlitz JR, Raymond EG, Bild DE, et al: Trial of Calcium to Prevent Preeclampsia. N Engl J Med 1997, 337(2):69-77.
51. Kuklina EV, Ayala C, Callaghan WM: Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009, 113(6):1299-1306.
52. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, et al: Prevention of Preeclampsia with Low-Dose Aspirin in Healthy, Nulliparous Pregnant Women. N Engl J Med 1993, 329(17):1213-1218. (Pubitemid 23306321)
53. anonymous: Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.[see comment]. Lancet 1995, 346(8990):1575-1582.
54. anonymous: Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.[see comment]. Lancet 1996, 348(9026):505-510.
55. Croft P, Hannaford PC: Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.[see comment]. BMJ 1989, 298(6667):165-168. (Pubitemid 19039682)
56. Mann JI, Doll R, Thorogood M, Vessey MP, Waters WE: Risk factors for myocardial infarction in young women. Br J Prev Soc Med 1976, 30(2):94-100.
57. Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D, Mosley TH, Wiste HJ, Turner ST: Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens 2010, 28:826-833.
58. Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, Schwartz SM: Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 2003, 42(5):982-989. (Pubitemid 37322915)
59. Hannaford P, Ferry S, Hirsch S: Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997, 77(2):154-158. (Pubitemid 27115799)
60. Smith GC, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001, 357(9273):2002-2006. (Pubitemid 32592386)
61. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA: Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366(9499):1797-1803. (Pubitemid 41642644)
62. Wikstrom A-K, Haglund B, Olovsson M, Lindeberg SN: The risk of maternal ischaemic heart disease after gestational hypertensive disease. Br J Obstet Gynaecol 2005, 112(11):1486-1491. (Pubitemid 43961234)
63. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC: Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326(7394):845.
64. Arnadottir GA, Geirsson RT, Arngrimsson R, Jonsdottir LS, Olafsson O: Cardiovascular death in women who had hypertension in pregnancy: a case-control study. Br J Obstet Gynaecol 2005, 112(3):286-292. (Pubitemid 40314002)
65. Funai EF, Friedlander Y, Paltiel O, Tiram E, Xue X, Deutsch L, Harlap S: Longterm mortality after preeclampsia. Epidemiology 2005, 16(2):206-215.
66. Irgens HU, Reisaeter L, Irgens LM, Lie RT: Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323(7323):1213-1217.
67. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N: Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995, 74(10):772-776. (Pubitemid 26002174)
68. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ: Preeclampsia and the Risk of Ischemic Stroke Among Young Women: Results From the Stroke Prevention in Young Women Study. Stroke 2006, 37(4):1055-1059.
69. Garovic VD, Hayman SR: Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007, 3(11):613-622. (Pubitemid 350012820)
70. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS: Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001, 285(12):1607-1612. (Pubitemid 32240253)
71. North RA, Simmons D, Barnfather D, Upjohn M: What happens to women with preeclampsia? Microalbuminuria and hypertension following preeclampsia. Aust N Z J Obstet Gyneacol 1996, 36(3):233-238. (Pubitemid 26278516)
72. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B: Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertens Res 2011, 58(4):709-715.
73. Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown RD Jr: Premature menopause or early menopause and risk of ischemic stroke. Menopause 2012, 19(3):272-277.
74. Chen S-J, Li H, Durand J, Oparil S, Chen Y-F: Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996, 93:577-584. (Pubitemid 26043619)
75. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME: Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res 2001, 89:534-539. (Pubitemid 34133991)
76. White CR, Shelton J, Chen S-J, Darley-Usmar V, Allen L, Nabors C, Sanders PW, Chen Y-F, Oparil S: Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation 1998, 96:1624-1630.
77. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA: Premature menopause or early menopause: long-term health consequences. Maturitas 2010, 65:161-166.
78. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. J Am Med Assoc 1991, 265(14):1861-1867.
79. Ernster VL, Bush TL, Huggins GR, Hullka BS, Kelsey JL, Schottenfeld D: Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med 1988, 17:201-223.
80. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr: Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996, 87(1):6-12. (Pubitemid 26015941)
81. Bass KM, Bush TL: Estrogen therapy and cardiovascular risk in women. J La State Med Soc 1991, 143:33-39.
82. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987, 75:1102-1109. (Pubitemid 17081015)
83. Bush TL, Cowan LD, Barrett-Connor E, Criqui MH, Karon JM, Wallace RB, Tyroler HA, Rifkind BM: Estrogen use and all-cause mortality. preliminary results from the lipid research clinics program follow-up study. JAMA 1983, 249(7):903-906. (Pubitemid 13143290)
84. Miller VT, Larosa J, Barnabei V, Kessler C, Levin G, Smithroth A, Griffin M, Stoy DB, Bush T, Zacur H, et al: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995, 273(3):199-208.
85. Hodis H, Mack W, Lobo R, Shoupe D, Sevanian A, Mahrer P, Selzer R, Liu C, Liu C, Azen S: Estrogen in the Prevention of Atherosclerosis. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 135(11):939-953. (Pubitemid 33131615)
86. Clarkson TB, Appt SE: Coronary artery disease and postmenopausal hormone therapy: is there a time window for prevention? Gynaecol Forum 2004, 9:11-14. (Pubitemid 39270296)
87. Hodis HN, Bauer HJ, Rawlins DB, Mack WJ: A "window of opportunity:" The reduction of coronary heart disease and total mortality with menopausal therapies is age and time dependent. Brain Res 2011, 1379:244-252.
88. Rocca WA, Grossardt BR, Shuster LT: Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011, 1379:188-198.
89. Ashraf MS, Vongpatanasin W: Estrogen and hypertension. Curr Hypertens Rep 2006, 8(5):368-376. (Pubitemid 44463720)
90. Angerer P, Stork S, von Schacky C: Influence of 17beta-oestradiol on blood pressure of postmenopausal women at high vascular risk. J Hypertens 2001, 19(12):2135-2142. (Pubitemid 33135233)
91. Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL: Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 2001, 135(4):229-238. (Pubitemid 32799336)
92. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P: The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002, 16(7):509-516. (Pubitemid 34790343)
93. Andersen K, Launer LJ, Dewey ME, Letenneur L, Ott A, Copeland JR, Dartigues JF, Kragh-Sorensen P, Baldereschi M, Brayne C, et al: Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999, 53(9):1992-1997.
94. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B: Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 1997, 48(1):132-138. (Pubitemid 27039531)
95. Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L: Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 2002, 58(2):209-218. (Pubitemid 34084209)
96. Lobo A, Lopez-Anton R, Santabarbara J, De-la-Camara C, Ventura T, Quintanilla MA, Roy JF, Campayo AJ, Lobo E, Palomo T, et al: Incidence and lifetime risk of dementia and Alzheimer's disease in a Southern European population. Acta Psychiatr Scand 2011, 124(5):372-383.
97. Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B: Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 1998, 46(4):444-452. (Pubitemid 28188517)
98. Tschanz JT, Corcoran CD, Schwartz S, Treiber K, Green RC, Norton MC, Mielke MM, Piercy K, Steinberg M, Rabins PV, et al: Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the cache county dementia progression study. Am J Geriatr Psychiatry 2011, 19(6):532-542.
99. Mielke MM, Leoutsakos JM, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Tschanz JT, Lyketsos CG: Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression. Alzheimers Dement 2012, 8(3):180-187.
100. Rhodes M, O'Toole S, Wright S, Czambel R, Rubin R: Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Res Bull 2001, 54:101-113. (Pubitemid 32156921)
101. Luine V, Renner K, McEwen B: Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments. Endocrinol Metab Clin North Am 1986, 119:874-878. (Pubitemid 16048849)
102. Hortnagl H, Hansen L, Kindel G, Schneider B, El Tamer A, Hanin I: Sex differences and estrous cycle-variations in the AF64A-induced cholinergic deficit in the rat hippocampus. Brain Res Bull 1993, 31:129-34. (Pubitemid 23102834)
103. Wang R, Schorer-Apelbaum D, Weinstock M: Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine. Eur J Pharmacol 2001, 433:73-79. (Pubitemid 34038083)
104. Wang RH, Bejar C, Weinstock M: Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 2000, 39:497-506. (Pubitemid 30052938)
105. Vinters HV: Cerebral amyloid angiopathy. a critical review. Stroke 1987, 18:311-324. (Pubitemid 17059655)
106. Kalaria RN, Hedera P: Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 1995, 6:477-480.
107. Perlmutter LS, Chui HC: Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res Bull 1990, 24:677-686. (Pubitemid 20183782)
108. Sparks DL, Hunsaker JC 3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990, 11(6):601-607.
109. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347(9009):1141-1145. (Pubitemid 126512042)
110. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ: Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000, 21(1):49-55. (Pubitemid 30224785)
111. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997, 349(9046):151-154. (Pubitemid 27039193)
112. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a population-based study. the Rotterdam study. Stroke 1997, 28(2):316-321. (Pubitemid 27096997)
113. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, et al: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45(6):1161-1168.
114. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999, 53(9):1937-1942.
115. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I: An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003, 163(13):1524-1528. (Pubitemid 36835095)
116. Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J, Stern Y, Mayeux R: Stroke and the risk of Alzheimer disease. Arch Neurol 2003, 60(12):1707-1712. (Pubitemid 37521623)
117. Mielke MM, Rosenberg P, Tschanz JT, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PVR, Green R, Welsh-Bohmer K, et al: Vascular factors predict rate of progression in Alzheimer's disease. Neurology 2007, 69:1850-1858. (Pubitemid 350071146)
118. Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG: Cerebral infarction in eclampsia. Am J Obstet Gynecol 2004, 190(3):714-720. (Pubitemid 38406783)
119. Wagner S, Acquah L, Lindell E, Craici I, Wingo M, Rose C, White W, August P, Garovic V: Posterior Reversible Encephalopathy Syndrome (PRES) and Eclampsia: Pressing the Case for More Aggressive Blood Pressure Control. Mayo Clin Proc 2011, 86:851-856.
120. van Straaten EC, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, Jack CR Jr, DeCarli C: Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 2008, 255(9):1302-1308.
121. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR: Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008, 65(1):94-100.
122. Aukes AM, De Groot JC, Aarnoudse JG, Zeeman GG: Brain lesions several years after eclampsia. Am J Obstet Gynecol 2009, 200(5):504. e501-505.
123. Brusse I, Duvekot J, Jongerling J, Steegers E, De Koning I: Impaired maternal cognitive functioning after pregnancies complicated by severe pre-eclampsia: a pilot case-control study. Acta Obstet Gynecol Scand 2008, 87(4):408-412. (Pubitemid 351481704)
124. Toda N, Ayajiki K, Okamura T: Cerebral blood flow regulation by nitric oxide in neurological disorders. Can J Physiol Pharmacol 2009, 87(8):581-594.
125. Lavi S, Gaitini D, Milloul V, Jacob G: Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2006, 291(4):H1856-1861. (Pubitemid 44497693)
126. Galvin SD, Celi LA, Thomas KN, Clendon TR, Galvin IF, Bunton RW, Ainslie PN: Effects of age and coronary artery disease on cerebrovascular reactivity to carbon dioxide in humans. Anaesth Intensive Care 2010, 38(4):710-717.
127. Katusic ZS, Vanhoutte PM: Anoxic contractions in isolated canine cerebral arteries: Contribution of endothelium-derived factors, metabolites of arachidonic acid and calcium entry. J Cardiovasc Pharmacol 1986, 8:S97-S101. (Pubitemid 17231427)
128. Katusic ZS, Vanhoutte PM: Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 1989, 257:H33-H37.
129. Guo J, Krause DN, Horne J, Weiss JH, Li X, Duckles SP: Estrogen-receptormediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab 2010, 30(3):545-554.
130. Xie A, Skatrud JB, Morgan B, Chenuel B, Khayat R, Reichmuth K, Lin J, Dempsey JA: Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans. J Physiol 2006, 577(Pt 1):319-329. (Pubitemid 44698258)
131. Barnes JN, Schmidt JE, Nicholson WT, Joyner MJ: Cyclooxygenase inhibition abolishes age-related differences in cerebral vasodilator responses to hypercapnia. J Appl Physiol 2012, 112(11):1884-1890.
132. Kastrup A, Dichgans J, Niemeier M, Schabet M: Changes of cerebrovascular CO2 reactivity during normal aging. Stroke 1998, 29(7):1311-1314. (Pubitemid 28300061)
133. Deegan BM, Sorond FA, Galica A, Lipsitz LA, O'Laighin G, Serrador JM: Elderly women regulate brain blood flow better than men do. Stroke 2011, 42(7):1988-1993.
134. Lampinen KH, Ronnback M, Kaaja RJ, Groop PH: Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006, 24(4):751-756.
135. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE: Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994, 24:471-476. (Pubitemid 24246550)
136. Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Fujii H, Ogawa H, Yasue H: Gender difference in improvement of endotheliumdependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997, 30:914-919. (Pubitemid 27435881)
137. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, Ganz P, Creager MA: Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998, 98(12):1158-1163. (Pubitemid 28436164)
138. Sorensen KE, Dorup I, Hermann AP, Mosekilde L: Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998, 97(13):1234-1238. (Pubitemid 28169174)
139. Emre A, Sahin S, Erzik C, Nurkalem Z, Oz D, Cirakoglu B, Yesilcimen K, Ersek B: Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease. Cardiology 2006, 106(1):44-50. (Pubitemid 43999332)
140. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM: Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 1997, 349:1146-1147. (Pubitemid 27168554)
141. Sudhir K, Komesaroff PA: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab 1999, 84:3411-3415.
142. Lew R, Komesaroff P, Williams M, Dawood T, Sudhir K: Endogenous estrogens influence endothelial function in young men. Circ Res 2003, 93:1127-1133. (Pubitemid 37485045)
143. Resnick SM, Metter EJ, Zonderman AB: Estrogen replacement therapy and longitudinal decline in visual memory. A possible protective effect? Neurology 1997, 49(6):1491-1497. (Pubitemid 28015106)
144. Rice MM, Graves AB, McCurry SM, Gibbons LE, Bowen JD, McCormick WC, Larson EB: Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. Arch Intern Med 2000, 160(11):1641-1649. (Pubitemid 30367903)
145. Steffens DC, Norton MC, Plassman BL, Tschanz JT, Wyse BW, Welsh-Bohmer KA, Anthony JC, Breitner JC: Enhanced cognitive performance with estrogen use in
146. Grodstein F, Chen J, Pollen DA, Albert MS, Wilson RS, Folstein MF, Evans DA, Stampfer MJ: Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 2000, 48(7):746-752. (Pubitemid 30457411)
147. Matthews K, Cauley J, Yaffe K, Zmuda JM: Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999, 47(5):518-523. (Pubitemid 29215577)
148. O'Hara R, Schroder CM, Bloss C, Bailey AM, Alyeshmerni AM, Mumenthaler MS, Friedman LF, Yesavage JA: Hormone replacement therapy and longitudinal cognitive performance in postmenopausal women. Am J Geriatr Psychiatry 2005, 13(12):1107-1110. (Pubitemid 46638656)
149. de Moraes SA, Szklo M, Knopman D, Park E: Prospective assessment of estrogen replacement therapy and cognitive functioning: atherosclerosis risk in communities study. Am J Epidemiol 2001, 154(8):733-739. (Pubitemid 32971494)
150. File SE, Heard JE, Rymer J: Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology (Berl) 2002, 161(1):107-112. (Pubitemid 34437976)
151. Fillenbaum GG, Hanlon JT, Landerman LR, Schmader KE: Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Am J Epidemiol 2001, 153(2):137-144. (Pubitemid 32060604)
152. Craig MC, Maki PM, Murphy DG: The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 2005, 4(3):190-194. (Pubitemid 40269149)
153. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN: The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998, 19(6):604-621. (Pubitemid 29057725)
154. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd: Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69(11):1074-1083. (Pubitemid 47517552)
155. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J: The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101(3):485-512.
156. LeBlanc ES, Janowsky J, Chan BK, Nelson HD: Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001, 285(11):1489-1499. (Pubitemid 32221898)
157. Yaffe K, Sawaya G, Lieberburg I, Grady D: Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998, 279(9):688-695. (Pubitemid 28138739)
158. Sherwin BB, Henry JF: Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol 2008, 29(1):88-113.
159. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA: Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13(3):411-422.
160. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17(5):485-495. (Pubitemid 23015018)
161. Schmidt R, Fazekas F, Reinhart B, Kapeller P, Fazekas G, Offenbacher H, Eber B, Schumacher M, Freidl W: Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc 1996, 44(11):1307-1313. (Pubitemid 26374806)
162. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, et al: Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24):2959-2968. (Pubitemid 38802685)
163. Espeland MA, Tindle HA, Bushnell CA, Jaramillo SA, Kuller LH, Margolis KL, et al: Brain Volumes, Cognitive Impairment, and Conjugated Equine Estrogens. J Gerontol A Biol Sci Med Sci 2009, 64:1243-1250.
164. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, et al: Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289(20):2663-2672. (Pubitemid 37430137)
165. Shaywitz SE, Naftolin F, Zelterman D, Marchione KE, Holahan JM, Palter SF, Shaywitz BA: Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003, 10(5):420-426.
166. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, et al: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24):2947-2958. (Pubitemid 38802684)
167. Morrison JH, Brinton RD, Schmidt PJ, Gore AC: Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci 2006, 26(41):10332-10348. (Pubitemid 44564581)
168. Sherwin BB: Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13(4):345-357.
169. Asthana S, Brinton RD, Henderson VW, McEwen BS, Morrison JH, Schmidt PJ: Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Age (Dordr) 2009, 31(3):199-210.
170. Resnick SM, Henderson VW: Hormone therapy and risk of Alzheimer disease: a critical time.[see comment][comment]. JAMA 2002, 288(17):2170-2172. (Pubitemid 35276517)
171. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA: Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005, 76(1):103-105. (Pubitemid 40013499)
172. Maki PM: Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience 2006, 138(3):1027-1030.
173. Murphy DD, Segal M: Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci 1996, 16(13):4059-4068. (Pubitemid 26192402)
174. Morrison JH: A mechanism emerges for the critical period hypothesis for estrogen treatment. Proc Natl Acad Sci USA 2011, 108(35):14375-14376. doi:10.1073/pnas.1111672108.
175. Aenlle KK, Kumar A, Cui L: Jackson TC. Foster TC: Estrogen effects on cognition and hippocampal transcription in middle-aged mice. Neurobiol Aging; 2007.
176. Gould E, Woolley CS, Frankfurt M, McEwen BS: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990, 10(4):1286-1291.
177. Woolley CS, Gould E, Frankfurt M, McEwen BS: Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990, 10(12):4035-4039.
178. Gibbs RB: Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann N Y Acad Sci 1994, 743:165-196. discussion 197-169.
179. Gibbs RB, Aggarwal P: Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav 1998, 34(2):98-111. (Pubitemid 28541752)
180. Luine VN: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985, 89(2):484-490. (Pubitemid 15040918)
181. Markowska AL, Savonenko AV: Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci 2002, 22(24):10985-10995. (Pubitemid 36005175)
182. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, Hogg PJ: Evidence for activation of tissue factor by an allosteric disulfide bond. Biochem Cell Biol 2006, 45:12020-12028. (Pubitemid 44497827)
183. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE: Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994, 269(18):13065-13068. (Pubitemid 24206062)
184. Green PS, Simpkins JW: Neuroprotective effects of estrogens: potential mechanisms of action. Int J Develop Neurosci 2000, 18:347-358. (Pubitemid 30243066)
185. Green PS, Gridley KE, Simpkins JW: Nuclear estrogen receptorindependent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998, 84(1):7-10. (Pubitemid 28081520)
186. Greene RA: Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Womens Med 2000, 45(4):253-257.
187. Dekaban AS: Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978, 4(4):345-356. (Pubitemid 9009863)
188. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW: Mapping cortical change across the human life span. Nat Neurosci 2003, 6(3):309-315. (Pubitemid 36278290)
189. Liu RS, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander JW, Duncan JS: A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage 2003, 20(1):22-33. (Pubitemid 37188496)
190. Bobinski M, Wegiel J, Tarnawski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM: Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 1997, 56(4):414-420. (Pubitemid 27465024)
191. Kantarci K, Jack CRJ: Quantitative magnetic resonance techniques as surrogate markers in Alzheimer's disease. NeuroRx 2004, 1:196-205. (Pubitemid 46589351)
192. Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, et al: Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008, 63(1):72-80. (Pubitemid 351240553)
193. Seliger SL, Longstreth WT Jr, Katz R, Manolio T, Fried LF, Shlipak M, Stehman-Breen CO, Newman A, Sarnak M, Gillen DL, et al: Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005, 16(12):3721-3727. (Pubitemid 46211294)
194. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, Matthews PM, Fazekas F: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005, 58(4):610-616. (Pubitemid 41377225)
195. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348(13):1215-1222. (Pubitemid 36359297)
196. Luchsinger J, Brickman A, Reitz C, Schupf N, Manly J, Tang M, Small S, Mayeux R, DeCarli C, Brown T: Cerebrovascular disease in mild cognitive impairment. Alzheimers Dement 2008, 4(4(2)):T131.
197. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001, 58(4):643-647. (Pubitemid 32295717)
198. Kantarci K, Miller VM, Zais TG, Gunter JL, Jack CRJ: Brain Volume Changes in Recently Menopausal Women in a Hormone Replacement Trial. Climacteric 2008, 11(2):342. 264.
199. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J: White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 2003, 60(3):393-398. (Pubitemid 36314365)
200. Yoshita M, Fletcher E, Harvey D, Ortega M, Martinez O, Mungas DM, Reed BR, DeCarli CS: Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006, 67(12):2192-2198. (Pubitemid 46035476)
201. Greenberg DL, Payne ME, MacFall JR, Provenzale JM, Steffens DC, Krishnan RR: Differences in brain volumes among males and female hormonetherapy users and nonusers. Psychiatry Res 2006, 147(2-3):127-134. (Pubitemid 44397462)
202. Low LF, Anstey KJ, Maller J, Kumar R, Wen W, Lux O, Salonikas C, Naidoo D, Sachdev P: Hormone replacement therapy, brain volumes and white matter in postmenopausal women aged 60-64 years. Neuroreport 2006, 17(1):101-104. (Pubitemid 43005749)
203. Boccardi M, Ghidoni R, Govoni S, Testa C, Benussi L, Bonetti M, Binetti G, Frisoni GB: Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. Menopause 2006, 13(4):584-591. (Pubitemid 44088351)
204. Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust WJ: Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 2003, 24(5):725-732. (Pubitemid 37288870)
205. Lord C, Buss C, Lupien SJ, Pruessner JC: Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging 2008, 29(1):95-101. (Pubitemid 350102707)
206. Erickson KI, Colcombe SJ, Raz N, Korol DL, Scalf P, Webb A, Cohen NJ, McAuley E, Kramer AF: Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging 2005, 26(8):1205-1213. (Pubitemid 40726014)
207. Ghidoni R, Boccardi M, Benussi L, Testa C, Villa A, Pievani M, Gigola L, Sabattoli F, Barbiero L, Frisoni GB, et al: Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 2006, 54(3):222-228. (Pubitemid 44250806)
208. Ha DM, Xu J, Janowsky JS: Preliminary evidence that long-term estrogen use reduces white matter loss in aging. Neurobiol Aging 2007, 28(12): 1936-1940. (Pubitemid 47539696)
209. Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C: Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009, 72(2):135-142.
210. Coker LH, Hogan PE, Bryan NR, Kuller LH, Margolis KL, Bettermann K, Wallace RB, Lao Z, Freeman R, Stefanick ML, et al: Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 2009, 72(2):125-134.
211. Kuller LH, Margolis KL, Gaussoin SA, Bryan NR, Kerwin D, Limacher M, Wassertheil-Smoller S, Williamson J, Robinson JG: Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) 2010, 12(3):203-212.
212. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM: Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2000, 69(4):528-530.
213. Sandson TA, Felician O, Edelman RR, Warach S: Diffusion-weighted magnetic resonance imaging in Alzheimer's disease. Dement Geriatr Cogn Disord 1999, 10(2):166-171. (Pubitemid 29099702)
214. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS: Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001, 57(12):2307-2310. (Pubitemid 34016470)
215. Lee DY, Fletcher E, Martinez O, Ortega M, Zozulya N, Kim J, Tran J, Buonocore M, Carmichael O, DeCarli C: Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 2009, 73(21):1722-1728.
216. Kantarci K: Diffusion Tensor Imaging in Alzheimer's Disease. Curr Med Imaging Rev 2011, 7(1):28-33.
217. Kantarci K, Senjem ML, Avula R, Zhang B, Samikoglu AR, Weigand SD, Przybelski SA, Edmonson HA, Vemuri P, Knopman DS, et al: Diffusion tensor imaging and cognitive function in older adults with no dementia. Neurology 2011, 77(1):26-34.
218. O'Sullivan M, Jones DK, Summers PE, Morris RG, Williams SC, Markus HS: Evidence for cortical "disconnection" as a mechanism of age-related cognitive decline. Neurology 2001, 57(4):632-638. (Pubitemid 32782990)
219. Davis SW, Dennis NA, Buchler NG, White LE, Madden DJ, Cabeza R: Assessing the effects of age on long white matter tracts using diffusion tensor tractography. Neuroimage 2009, 46(2):530-541.
220. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, et al: Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3):280-292.
221. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, et al: Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008, 131(Pt 6):1630-1645. (Pubitemid 351806448)
222. Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA: APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol 2010, 67(1):122-131.
223. Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, et al: APOE Modifies the Association Between A-Beta load and Cognition in Cognitively Normal Older Adults. Neurology 2012, 78(4):232-240.
224. Cohen RA, Shepherd JT, Vanhoutte PM: Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 1983, 221:273-274. (Pubitemid 13062619)
225. Houston DS, Shepherd JT, Vanhoutte PM: Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. J Clin Invest 1986, 78:539-544.
226. Lorenz RR, Vanhoutte PM: Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels. Am J Physiol 1985, 249:H685-H689. (Pubitemid 16227489)
227. Bracamonte MP, Rud KS, Owen WG, Miller VM: Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle. Am J Physiol Heart Circ Physiol 2002, 283:H853-H860.
228. Lewis DA, Avsar M, LaBreche P, Bracamonte MP, Jayachandran M, Miller VM: Treatment with raloxifene and 17beta-estradiol differentially modulates nitic oxide and prostanoids in venous endothelium and platelets of ovariectomized pigs. J Cardiovasc Pharmacol 2006, 48(5):231-238.
229. Bracamonte MP, Miller VM: Vascular effects of estrogens: arterial protection versus venous thrombotic risk. Trends Endocrinol Metab 2001, 12:204-209. (Pubitemid 33714206)
230. Jayachandran M, Miller VM: Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets. Am J Physiol Heart Circ Physiol 2002, 283:H220-H226. (Pubitemid 34705343)
231. Jayachandran M, Miller VM: Human platelets contain estrogen receptor a, caveolin-1 and estrogen receptor associated proteins. Platelets 2003, 14:75-81. (Pubitemid 36461463)
232. Jayachandran M, Owen WG, Miller VM: Effects of ovariectomy on aggregation, secretion, and metalloproteinases in porcine platelets. Am J Physiol Heart Circ Physiol 2003, 284:H1679-H1685. (Pubitemid 36460782)
233. Jayachandran M, Mukherjee R, Steinkamp T, LaBreche P, Bracamonte MP, Okano H, Owen WG, Miller VM: Differential effects of 17b-estradiol, conjugated equine estrogen and raloxifene on mRNA expression, aggregation and secretion in platelets. Am J Physiol Heart Circ Physiol 2005, 288:H2355-H2362.
234. Lewis DA, Bracamonte MP, Rud KS, Miller VM: Genome and hormones: gender differences in physiology selected contribution: effects of sex and ovariectomy on responses to platelets in porcine femoral veins. J Appl Physiol 2001, 91:2823-2830. (Pubitemid 33108050)
235. Kobayashi T, Tokunaga N, Sugimura M, Suzuki K, Kanayama N, Nishiguchi T, Terao T: Coagulation/fibrinolysis disorder in patients with severe preeclampsia. Semin Thromb Hemost 1999, 25(5):451-454. (Pubitemid 30010799)
236. Bosio PM, Cannon S, McKenna PJ, O'Herlihy C, Conroy R, Brady H: Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia. BJOG 2001, 108(7):709-715. (Pubitemid 32778277)
237. Mellembakken JR, Solum NO, Ueland T, Videm V, Aukrust P: Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia-possible role of platelet activation. Thromb Haemost 2001, 86(5):1272-1276. (Pubitemid 33064578)
238. Torres PJ, Escolar G, Palacio M, Gratacos E, Alonso PL, Ordinas A: Platelet sensitivity to prostaglandin E1 inhibition is reduced in pre-eclampsia but not in nonproteinuric gestational hypertension. Br J Obstet Gynaecol 1996, 103(1):19-24. (Pubitemid 26009920)
239. Valera MC, Parant O, Vayssiere C, Arnal JF, Payrastre B: Physiologic and pathologic changes of platelets in pregnancy. Platelets 2010, 21(8):587-595.
240. Stellos K, Panagiota V, Kogel A, Leyhe T, Gawaz M, Laske C: Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. J Cereb Blood Flow Metab 2010, 30(11):1817-1820.
241. Hochstrasser T, Ehrlich D, Marksteiner J, Sperner-Unterweger B, Humpel C: Matrix Metalloproteinase-2 and Epidermal Growth Factor are Decreased in Platelets of Alzheimer Patients. Curr Alzheimer Res 2011, 9:982-989. doi:10.2174/156720512803251156.
242. Jablonski M, Maciejewski R, Januszewski S, Ulamek M, Pluta R: One year follow up in ischemic brain injury and the role of Alzheimer factors. Physiol Res 2011, 60(Suppl 1):S113-119.
243. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A: Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001, 85(4):639-646. (Pubitemid 32293699)
244. Zwaal RF, Schroit AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132. (Pubitemid 27079974)
245. Morel O, Toti F, Hugel B, Camoin-Jau L, Dignat-George F, Freyssinet JM: Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? Arterioscler Thromb Vasc Biol 2006, 26:2594-2604.
246. Jayachandran M, Litwiller RD, Owen WG, Miller VM: Circulating microparticles and endogenous estrogen in newly menopausal women. Climacteric 2009, 12:177-184.
247. Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59(2):277-287. (Pubitemid 37272022)
248. Jayachandran M, Litwiller RD, Owen WG, Heit JA, Behrenbeck TR, Mulvagh SL, Araoz PA, Budoff MJ, Harman SM, Miller VM: Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol 2008, 295:931-938.
249. Jayachandran M, Litwiller RD, Lahr BD, Bailey KR, Owen WG, Mulvagh SL, Heit JA, Hodis HN, Harman SM, Miller VM: Alterations in Platelet Function and Cell-Derived Microvesicles in Recently Menopausal Women: Relationship to Metabolic Syndrome and Atherogenic Risk. J Cardiovasc Transl Res 2011, 4(6):811-822.
250. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N: KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005, 8:3-12. (Pubitemid 40675116)
251. Raz L, Jayachandran M, Tosakulwong N, Lesnick TG, Wille SM, Murphy MC, Senjem ML, Vermuri P, Jack CRJ, Miller VM, et al: Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology 2012. doi:10.1212/WNL.0b013e3182840c9f.